Clinical Trials at OCOM

Beckman Coulter MeMed BV Assay and Enrollment for Analysis of Biomarkers to Predict Disease Progression in the Emergency Department

You are being asked to take part in a research study. The information in this document should help you to decide if you would like to participate. The sections in this Overview provide the basic information about the study. More detailed information is contained in the consent form and includes:

  • Study Staff

  • Study Details

  • Subjects

  • Voluntary Participation

  • Benefits, Compensation, and Risk

  • Confidentiality

Please review the official consent form before continuing.

  • In-House Diagnostics

    Fully equipped phlebotomy station for on-site blood draws + centrifugation and biospecimen storage & disposal/waste

    Abbott Piccolo Xpress Chemistry Analyzer
    Tests include: metabolic panels, liver function, kidney function, lipids, and electrolytes

    McKesson Sysmex XW Hematology Analyzer
     Tests include: CBC, WBC differential, hemoglobin, hematocrit

    POC Rapid Testing
     On-site testing for: COVID-19 (antigen), Influenza A/B, Group A Streptococcus

  • Clinical Trial Milestones

    We have successfully completed two industry-sponsored trials:

    MeMed BV® Trial
    Assess the accuracy of host-response biomarkers to distinguish between bacterial and viral infections

    EPAPER
    Evaluate a novel hematology analyzer’s performance in emergency and outpatient settings
    *Revenue pending completion of Beckman’s final monitoring review